Company / Shares Outstanding
Inmune Bio, Inc. Shares Outstanding History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
22.3M
FY2025
5-year range
13.5M / 22.3M
FY2021-FY2025
Trend
+24.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 6 consecutive years, from 8319441.00 in FY2018 to 22280451.00 in FY2025.
Based on SEC 10-K filings.
22280451.00 in FY2025 with a 5-year CAGR of +15.6%.
Increased from 17945995.00 to 22280451.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +7.7%
- 5-Year CAGR
- +15.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Inmune Bio, Inc.'s shares outstanding has grown for 6 consecutive years.
- In FY2025, shares outstanding increased 24.1% year-over-year.
- Lowest shares outstanding in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 49.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 22.3M | +24.1% |
| FY2024 | 18.0M | +0.0% |
| FY2023 | 17.9M | +0.6% |
| FY2022 | 17.8M | +32.4% |
| FY2021 | 13.5M | +25.2% |
| FY2020 | 10.8M | +29.5% |
| FY2018 | 8.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026